Date post: | 21-Dec-2015 |
Category: |
Documents |
View: | 219 times |
Download: | 1 times |
Copyright (c) by W. H. Freeman and Company
24.1 Benign tumors arise with great frequency but pose little risk because they are localized and small
Figure 24-1
Copyright (c) by W. H. Freeman and Company
24.1 Malignant tumors generally invade surrounding tissue and spread throughout the body
Figure 24-2
Alterations in cell-cell interactions and the formation of new blood vessels are associated with malignancy
Copyright (c) by W. H. Freeman and Company
24.1 DNA from tumor cells can transform normal cultured cells
Figure 24-3
Cells that continue to grow when normal cells have become quiescent are said to be transformedTransformed cells may exhibit many of the properties of malignant tumor cells
normal transformed
Copyright (c) by W. H. Freeman and Company
24.1 The identification and molecular cloning of a specific DNA sequence that causes transformation
Figure 24-4
Copyright (c) by W. H. Freeman and Company
24.1 Epidemiology of human cancers indicates that development of cancer requires several mutations
Figure 24-5
Copyright (c) by W. H. Freeman and Company
24.1 The development of colon cancer is characterized by a well-ordered series of mutations
Figure 24-6
Inherited mutations intumor-suppressor genesincrease cancer risk
Copyright (c) by W. H. Freeman and Company
24.1 Overexpression of multiple oncogenes increases tumor formation
Figure 24-7
Copyright (c) by W. H. Freeman and Company
24.1 Cancers originate in proliferating cells
Figure 24-8
Formation of differentiated blood cells from hematopoieticstem cells in the bone marrow
Copyright (c) by W. H. Freeman and Company
24.2 Proto-oncogenes and tumor-suppressor genes: the seven types of proteins that participate in controlling cell growth
Figure 24-9
Copyright (c) by W. H. Freeman and Company
24.2 Gain-of-function mutations convert proto-oncogenes into oncogenes
Oncogenes were first identified in cancer-causing retroviruses The Rous sarcoma virus (RSV) contains a gene (src) that is
required for cancer-induction but is not required for viral function
Normal cells contain a related gene that codes for a protein-tyrosine kinase
The normal gene (c-src) is the proto-oncogene, while the viral gene (v-src) is an oncogene that codes for a constitutively active mutant protein-tyrosine kinase
Many DNA viruses also contain oncogenes but these have integral functions in viral replication
Copyright (c) by W. H. Freeman and Company
24.2 Slow-acting carcinogenic retroviruses can activate cellular proto-oncogenes
Figure 24-10
Copyright (c) by W. H. Freeman and Company
24.2 Loss-of-function mutations in tumor-suppressor genes are oncogenic
Figure 24-12
The first tumor-suppressor gene was identified in patients with inherited retinoblastoma
Copyright (c) by W. H. Freeman and Company
24.2 Loss of heterozygosity of tumor-suppressor genes occurs by chromosome mis-segregation or mitotic recombination
Figure 24-13
Copyright (c) by W. H. Freeman and Company
24.3 Virus-encoded activators of growth-factor receptors act as oncoproteins
Figure 24-14
Copyright (c) by W. H. Freeman and Company
24.3 Activating mutations or overexpression of growth-factor receptors can transform cells
Figure 24-15
Copyright (c) by W. H. Freeman and Company
24.3 A chimeric oncoprotein resulting from chromosomal translocation
Figure 24-16
Copyright (c) by W. H. Freeman and Company
24.3 Constitutively active signal-transduction proteins are encoded by many oncogenes
Figure 24-17
Copyright (c) by W. H. Freeman and Company
24.3 Inappropriate expression of nuclear transcription factors can induce transformation
Figure 24-18
Copyright (c) by W. H. Freeman and Company
24.4 Passage from G1 to S phase is controlled by proto-oncogenes and tumor-suppressor genes
Figure 24-19
Copyright (c) by W. H. Freeman and Company
24.4 Loss of TGF signaling contributes to abnormal cell proliferation and malignancy
Figure 24-20
Copyright (c) by W. H. Freeman and Company
24.5 Mutations in p53 abolish G1 checkpoint control
Figure 24-21
Some human carcinogens cause inactivating mutations in the p53 gene andp53 activity is also inhibited by certain proteins encoded by DNA tumor viruses
Copyright (c) by W. H. Freeman and Company
24.5 Defects in DNA-repair systems perpetuate mutations and are associated with certain cancers
Copyright (c) by W. H. Freeman and Company
24.5 Chromosomal abnormalities are common in human tumors
Figure 24-22